These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28479207)

  • 1. Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations.
    Smith SM; Jones JK; Katz NP; Roland CL; Setnik B; Trudeau JJ; Wright S; Burke LB; Comer SD; Dart RC; Dionne R; Haddox JD; Jaffe JH; Kopecky EA; Martell BA; Montoya ID; Stanton M; Wasan AD; Turk DC; Dworkin RH
    J Pain; 2017 Nov; 18(11):1287-1294. PubMed ID: 28479207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review.
    Smith SM; Paillard F; McKeown A; Burke LB; Edwards RR; Katz NP; Papadopoulos EJ; Rappaport BA; Slagle A; Strain EC; Wasan AD; Turk DC; Dworkin RH
    J Pain; 2015 May; 16(5):389-411. PubMed ID: 25660826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and feasibility of the misuse, abuse, and diversion drug event reporting system (MADDERS®).
    Treister R; Trudeau JJ; Van Inwegen R; Jones JK; Katz NP
    Am J Addict; 2016 Dec; 25(8):641-651. PubMed ID: 28051840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations.
    Smith SM; Dart RC; Katz NP; Paillard F; Adams EH; Comer SD; Degroot A; Edwards RR; Haddox DJ; Jaffe JH; Jones CM; Kleber HD; Kopecky EA; Markman JD; Montoya ID; O'Brien C; Roland CL; Stanton M; Strain EC; Vorsanger G; Wasan AD; Weiss RD; Turk DC; Dworkin RH
    Pain; 2013 Nov; 154(11):2287-2296. PubMed ID: 23792283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of potentially abuse-related events in two phase 3 studies of NKTR-181, a novel opioid analgesic, using the MADDERS® system (Misuse, Abuse, and Diversion Drug Event Reporting System).
    Lanier RK; Henningfield JE; Gudin J; Rauck R; Elder H; Erpelding N; Treister R; Gimbel J; Tagliaferri M; Doberstein SK; Di Fonzo CJ; Lu L; Siddhanti S; Katz NP
    Curr Med Res Opin; 2019 Sep; 35(9):1513-1522. PubMed ID: 30932719
    [No Abstract]   [Full Text] [Related]  

  • 6. The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain.
    Setnik B; Roland CL; Barsdorf AI; Brooks A; Coyne KS
    Curr Med Res Opin; 2017 Jun; 33(6):1067-1076. PubMed ID: 28277862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
    Setnik B; Roland CL; Pixton GC; Sommerville KW
    Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).
    Kaye AD; Jones MR; Kaye AM; Ripoll JG; Jones DE; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
    Pain Physician; 2017 Feb; 20(2S):S111-S133. PubMed ID: 28226334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
    Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
    Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
    Sehgal N; Manchikanti L; Smith HS
    Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety.
    Cheatle MD
    Pain Med; 2015 Oct; 16 Suppl 1():S3-8. PubMed ID: 26360931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits.
    Davis JM; Severtson SG; Bucher-Bartelson B; Dart RC
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):18-25. PubMed ID: 24130046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation Strategy.
    Bucher Bartelson B; Le Lait MC; Green JL; Cepeda MS; Coplan PM; Maziere JY; Wedin GP; Dart RC
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1061-1070. PubMed ID: 28758289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription Opioid Use and Misuse Among Older Adult Rhode Island Hospital Emergency Department Patients.
    Henderson AW; Babu KM; Merchant RC; Beaudoin FL
    R I Med J (2013); 2015 Mar; 98(3):28-31. PubMed ID: 26056833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the impact of abuse-deterrent opioids (ADOs): identifying epidemiologic factors related to new entrants with low population exposure.
    Roland CL; Setnik B; Brown DA
    Postgrad Med; 2017 Jan; 129(1):12-21. PubMed ID: 27960575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe pain.
    Setnik B; Roland CL; Sommerville KW; Pixton GC; Berke R; Calkins A; Goli V
    J Pain Res; 2015; 8():361-73. PubMed ID: 26185467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening in Trauma for Opioid Misuse Prevention (STOMP): study protocol for the development of an opioid risk screening tool for victims of injury.
    Brown R; Deyo B; Riley C; Quanbeck A; Glass JE; Turpin R; Hetzel S; Nicholas C; Cruz M; Agarwal S
    Addict Sci Clin Pract; 2017 Dec; 12(1):28. PubMed ID: 29198186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain.
    Hale ME; Moe D; Bond M; Gasior M; Malamut R
    Pain Manag; 2016 Oct; 6(5):497-508. PubMed ID: 27050830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations.
    O'Connor AB; Turk DC; Dworkin RH; Katz NP; Colucci R; Haythornthwaite JA; Klein M; O'Brien C; Posner K; Rappaport BA; Reisfield G; Adams EH; Balster RL; Bigelow GE; Burke LB; Comer SD; Cone E; Cowan P; Denisco RA; Farrar JT; Foltin RW; Haddox DJ; Hertz S; Jay GW; Junor R; Kopecky EA; Leiderman DB; McDermott MP; Palmer PP; Raja SN; Rauschkolb C; Rowbotham MC; Sampaio C; Setnik B; Smith SM; Sokolowska M; Stauffer JW; Walsh SL; Zacny JP
    Pain; 2013 Nov; 154(11):2324-2334. PubMed ID: 24148704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses.
    Bi-Mohammed Z; Wright NM; Hearty P; King N; Gavin H
    Drug Alcohol Depend; 2017 Feb; 171():122-131. PubMed ID: 28086177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.